Novartis AG
Nucleic acids and proteins from streptococcus groups A and B
Last updated:
Abstract:
The invention provides proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes), including amino acid sequences and the corresponding nucleotide sequences. Data are given to show that the proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics. The proteins are also targets for antibiotics.
Status:
Grant
Type:
Utility
Filling date:
7 Nov 2017
Issue date:
1 Oct 2019